CannabisNewsBreaks

WednesdayFeb 10, 2021 12:56 pm

CBDNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Releases Q3 Financial Report

Canopy Rivers (TSX: RIV) (OTC: CNPOF), an investment and acquisition company specializing in cannabis, has shared financial numbers for its most recent period, the three and nine months ended Dec. 31, 2020. The announcement included both unaudited condensed interim consolidated financial statements and management's discussion and analysis ("MD&A"). Numbers in the report indicate that Canopy Rivers’ comprehensive income was $82.2 million, which the company notes was driven by an increase in the value of its investment in TerrAscend. The company also announced a “transformative and accretive” transaction with Canopy Growth; the transaction is scheduled to close by the end of February…

Continue Reading

WednesdayFeb 10, 2021 10:08 am

CBDNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces First Commercial Contract for CBD Oil

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company specializing in cannabis, hemp and mushroom products, has contracted for its initial commercial CBD oil sale. The company anticipated the contract will result in multiple shipments of its 85% pure CBD distillate offering this year. Pure Extracts’ state-of-the-art, subcritical/super-critical CO2 extraction system produces an exceptionally pure THC and CBD full-spectrum oil and distillate. The resulting distillate can be used to manufacture a variety of cannabis 2.0 products, such as beverages, edibles and vape pens. The announcement also noted that Pure Extracts continues its commitment to increase awareness.…

Continue Reading

TuesdayFeb 09, 2021 11:48 am

CBDNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) CMO to Serve 2nd Consecutive Term as President of US Hemp Roundtable

HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, today announced that its Chief Marketing Officer, Ola Lessard, was elected president of the U.S. Hemp Roundtable for a second consecutive term. The “Roundtable” is one of the most influential non-profit organizations advocating for national hemp legislation in the United States. This election makes Lessard not only the first woman, but also the first two-term president in the organization’s history. “I am truly honored by the confidence my peers have shown in me by electing me to a…

Continue Reading

TuesdayFeb 09, 2021 11:19 am

CBDNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Preliminary Q4 2020 Revenue, Forecast Numbers

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organically grown cannabis, has announced its Q4 2020 preliminary, unaudited revenue numbers. According to the release, the company reached $10.9 million in unaudited gross revenue in Q4 2020 for the period, with an increase in quarter-over-quarter revenue of 91%. The company also released an updated revenue forecast. The Q4 revenue is a 235% increase over the previous year. In the announcement, the company noted that the numbers reflect the significant progress and growth achieved in its Canadian operations and sales, which accounted for $8.6 million of the…

Continue Reading

MondayFeb 08, 2021 2:44 pm

CBDNewsBreaks – CBD.market Expects Newcomer Growth in 2021

CBD.market, an education-focused online CBD products store, predicts that 2021 will see substantial growth in the number of newcomers entering the CBD market. An increase in the number of CBD consumers will drive the demand for a wide variety of products and necessitate the need for more online retailers. According to High Yield Insights, many new users discovered the benefits of CBD products in the last six months of 2020. During that time, almost one in four CBD users entered the U.S. market, increasing the number of users by 9 million. In addition to new customers, one-third of established consumers…

Continue Reading

MondayFeb 08, 2021 11:11 am

CBDNewsBreaks – Grapefruit USA Inc. (GPFT) Releases Preliminary Revenue Numbers, Notes 714% Growth for Calendar Year

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, announced its unaudited revenue results for calendar year 2020. The numbers indicate that Grapefruit totaled revenues of an estimated $3,672,353 for the year ended Dec. 31, 2020, which represents an increase of approximately $3,221,156 from 2019. The announcement noted that, based on those preliminary numbers, the company is reporting revenue growth of 714% in 2020. The company has spent the last year and a half focused on bringing its patented Hourglass(TM) topical THC/cannabinoid delivery cream to market. Demand for the disruptive product has been robust, the company reported, with…

Continue Reading

ThursdayFeb 04, 2021 3:25 pm

CBDNewsBreaks – CannAssist International Corporation (CNSC) Pioneers Promising CiBiDinol Technology

CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, believes that its proprietary CiBiDinol technology will be a game-changer. According to a recent article, “the company believes that the amount of CBD needed to achieve the targeted therapeutic effects can be reduced significantly, resulting in reduced costs for both manufacturers and consumers.” CBD-based products “reduce inflammation while providing pain relief.” They are also the preferred option because they are “a gentler way to relieve pain and reduce inflammation,” unlike mainstream pharmaceuticals that have dangerous toxicity levels. CiBiDinol’s high efficacy per dose was the subject of “testing conducted via third-party services…

Continue Reading

ThursdayFeb 04, 2021 2:08 pm

CBDNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) Builds on Success, Launches into 2021 with Exciting Projects

Pac Roots (CSE: PACR), an innovative genetics-based cannabis company located in Canada, recently provided an update to investors and stakeholders following the first hemp harvest on its 100-acre site situated in British Columbia’s South Okanagan Valley. Pac Roots announced the remarkable success of its initial harvest, which yielded a quality far higher than expected. The company also announced that it would process and sell the entire >105,000-pound biomass to Speakeasy Cannabis Club (CSE: EASY).  A recent article covered this as well as the company’s low-cost production capabilities, which Pac Roots believes provide a sustainable competitive advantage and the ability to…

Continue Reading

WednesdayFeb 03, 2021 12:10 pm

CBDNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) to Hold Extraordinary Meeting of Debentureholders

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp-branded products company in the United States, has announced an upcoming shareholder meeting. The meeting, scheduled for 10 a.m. ET on Feb. 25, 2021, is an extraordinary meeting of holders of 8% unsecured convertible debentures that are due Feb. 28, 2021. Information containing detailed information regarding the amendments and resolutions to be considered during the meeting has been mailed to the company’s debentureholders of record. The meeting will be held virtually to maintain COVID-19 social distancing requirements; participants will be attending via a telephone conference. The announcement noted that the company’s…

Continue Reading

WednesdayFeb 03, 2021 11:13 am

CBDNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Signs Production Agreement with Applied Pharmaceutical Innovation

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, announced that it has signed an agreement with Applied Pharmaceutical Innovation. A not-for-profit institution at the University of Alberta, Applied supports translational drug development for industry and innovators. XPhyto’s psychedelic pharmaceutical production agreement calls for the synthesis of pharmaceutical-grade psychedelic compounds and the development of the standard operating procedures required to obtain regulatory approval for the commercial production process. As part of its psychedelic pharmaceutical program, XPhyto needs industrial-scale production of standardized active pharmaceutical ingredients. This agreement is part of that strategic…

Continue Reading